Ugo De Giorgi, Neeraj Agarwal, Neal D. Shore, Pedro C. Barata, Karim Olivier Fizazi, Nobuaki Matsubara, Stefanie Zschaebitz, Joan Carles, Andre P. Fay, Michael A. Zielinski, Fong Wang, Xun Lin, Rossella Messina, Arun Azad. "Impact of baseline demographics on therapy management in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with talazoparib (TALA) + enzalutamide (ENZA) in the TALAPRO-2 study: Extended follow-up.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5043